CYTOTRON
 
  Shréis-Scalene
Cytotron
Arthritis
Cancer                            Multiple Sclerosis
Clinical Studies
Scientific Research
Inventor                         The Team
FAQ                              
In The News
 
 
 

Shreis-Scalene Sciences
11516 Darnestown Rd. Gaithersburg,MD 20878
Tel : (001)301-926-0566
Fax : (001)301-926-2925
email : Shréis.com

 

 

BREAKING NEWS!

Clinical Trial in cancer treatment for all solid tumors planned in Mexico - June 2017

Clinical Trial in Musculo Skeletal disorders (Osteoarthritis) treatment planned in Mexico - June 2017

Parkinson's Disease successfully treated using Cytotron at Scalene CARD Campus, Bangalore, India - Boon for Parkinson Patients - 2016.

Alzheimer's Disease successfully treated using Cytotron at Scalene CARD Campus, Bangalore, India - Patients can visit Scalene, Bangalore, India

Stroke victims successfully treated using Cytotron at Scalene CARD Campus, Bangalore, India - Thanks to Dr. Rajah Vijay Kumar D.Sc.

Cytotron is awarded US Patent 20 October 2015 ( US 9,162,076 B2 )

Cytotron is awarded European Patent 11 March 2015 ( EP 1 753 508 B1 )

Cytotron received Mexican COFEPRIS import permit.

Cytotron receives Saudi Food and Drug Authority (SFDA) Approval - 01 September 2013

Governor of Maryland visits India - Meets Shreis Scalene Sciences' partner Dr. Rajah Vijay Kumar.  

Cytotron awarded Chinese Patent (08-09-2010)

Prof. Meena Augustus Ph.D , co-founder and CSO of Shreis Scalene Sciences LLC takes over as CEO of the company from April 2011.   Prof. Augustus will also continue to serve the company as its Chief Scientific Officer.

Shreis Scalene Sciences LLC (USA) awarded US Government IRS-Qualifying Therapeutic Discovery Project Program (QTDP) Grant under section 48D of Internal Revenue Code for:

"The Cytotron - a novel, stand alone therapeutic deice utilizing non-ionizing Rotational Field Quantum Magnetic Resonance to treat cancer AND  To Improve Drug Targeting & delivery through Nano-Permeabilization "

New Developments

  Cytotron developed by Scalene Cybernetics at its S-CARD campus, Bangalore, India, receives Chinese Patent

   Shreis Scalene Sciences signs license agreement with Technology Partner Scalene Cybernetics Bangalore,India for the use of Cytotron in the treatment of Multiple Sclerosis.  Clinical Trial registered with NIH ClinicalTrials.gov Identifier: NCT01220830

   Shreis Scalene Sciences  signs license agreement with Technology Partner Scalene Cybernetics Bangalore, India for the use of Cytotron in the treatment of cancer using Focused Resonance Nano Permeabilization  (FORN)

(WO/2010/106544) A METHOD AND APPARATUS FOR - FOCUSED RESONANCE NANOPERMEABILIZATION (FORN)

  

In The News

 

In the NEWS 

RFQMR



The Hindu
Red Herring
Sibia
Living
Deccan Herald

Haemoseis-256

The Hindu            Healthcare Mgt
IEEE
Business Line
Indo-American
Deccan Herald     PharmaBiz

 

Engineering Solutions to Human Problems